Conclusions.
In a sample of LBP patients who were treated with gabapentin because
they were diagnosed with potential LRP by the BUAS test, all of the
study’s prespecified endpoints of MICC in PD and BPI outcome changes
were reached. These results may be considered a piece of
ex-adiuvantibus evidence for the ability of the BUAS test to detect
lumbar-RP. While positive BUAS test implies potential lumbar-RP, the
co-presence of positive SLRT, may imply a severer lumbar-RP condition.
To generalize findings, more prospective research in different clinical
settings and direct clinical measures is needed.